Shares of Moolec Science SA (NASDAQ:MLEC) are trading higher after the company said it received approval for its plant-grown animal proteins.

The Animal and Plant Health Inspection Service (APHIS) of the U.S. Department of Agriculture (USDA) has concluded its Regulatory Status Review (RSR) for Moolec's genetically engineered (GE) soybean Piggy Sooy.

The USDA-APHIS RSR has concluded that Moolec's genetically engineered soybean, accumulating animal meat protein, is unlikely to pose an increased plant pest risk compared to non-engineered soybeans.

So, the Piggy Sooy product is not subject to the APHIS regulation that governs the movement of organisms modified or produced through genetic engineering.

"We achieved an unprecedented milestone in biotechnology with the first-ever USDA-APHIS approval of this kind," stated CEO and Co-Founder Gastón Paladini.

In June 2023, the company announced that Piggy Sooy seeds had achieved high levels of expression of pork protein (up to 26.6% of the total soluble protein) and had patented their technology.

Price Action: MLEC shares are trading higher by 112.9% at $2.98 premarket on the last check Monday.

Image: DALL·E AI